Simulations Plus

Lancaster, CA · United States

PK/PD & Biosimulationmid

Specialization: ADMET / PBPK Software

Key Differentiator

NASDAQ: SLP; only independent publicly-traded biosimulation company; GastroPlus = gold standard for oral absorption prediction; expanded into AI-driven training (2024-2025)

Core Services

GastroPlus (PBPK absorption modeling), ADMET Predictor, MembranePlus, MonolixSuite (popPK), PKPlus, DDDPlus (drug dissolution), AI-driven training platforms

Capabilities

GastroPlus (PBPK absorption modeling)ADMET PredictorMembranePlusMonolixSuite (popPK)PKPlusDDDPlus (drug dissolution)AI driven training platforms

Market Intelligence

Biosimulation software = 60-65% of market revenue; growing regulatory mandate for MIDD (FDA MIPD program)

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.